Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: Analysis of 702 patients after 10-year follow-up

Chang H.-C.Chen C.-L.Chiu T.-L.Chen S.-I.Yen A.M.-F.Chen, Tony Hsiu HsiTony Hsiu HsiChen2022-04-212022-04-2120091368-9800https://www.scopus.com/inward/record.uri?eid=2-s2.0-74949106869&doi=10.1017%2fS1368980009005308&partnerID=40&md5=b0c522ec407497a181d022eb21ff85d1https://scholars.lib.ntu.edu.tw/handle/123456789/605415[SDGs]SDG3Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: Analysis of 702 patients after 10-year follow-upjournal article10.1017/S1368980009005308193445402-s2.0-74949106869